WHO Adds Janssen Vaccine to List of Covid-19 Emergency Tools

The World Health Organization has listed the Covid-19 vaccine Ad26.COV2.S, developed by Janssen, a pharmaceutical firm owned by Johnson & Johnson, for emergency use in all countries and as part of the Covax roll-out. The decision comes on the back of the European Medicines Agency authorisation. As of March 25, 2021, Africa has confirmed 4,133,971 cases of Covid-19 across the continent of which 110,807 proved fatal and 3,708,871 resulted in recoveries, while 5,715,151 vaccinations have been administered.



A medic prepares a dose of the Covid-19 vaccine to be administered to a patient (file photo).

Don't Miss

AllAfrica publishes around 800 reports a day from more than 130 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.